Adenocarcinoma of the Pancreas Recruiting Phase 1 / 2 Trials for Ramucirumab (DB05578)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting1 / 2 IdentifierTitlePurposeDrugs
NCT03745430RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic AdenocarcinomaTreatment